Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Proteome Sciences PLC - drug development services provider - Says it has hired Abdelghani Omari as its new chief financial officer, effective on September 1. Says he will also become the director of the company. Proteome says Omari will join from speciality pharmaceutical company Paion AG, where he has been the chief financial officer since 2014.
Chief Executive Officer Mariola Soehngen says: ‘Abdel brings a wealth of relevant experience to the team as we pursue the company's strategy of organic growth, to grow the business through adding new high value services to our portfolio and enter into further internationalisation of the business.’
Current stock price: 3.82 pence
12-month change: down 34%
Copyright 2022 Alliance News Limited. All Rights Reserved.